Human Clinical: Selenium Yeast Reduces Oxidative Stress In Men
For the first time ever, researchers have made a significant positive connection between biomarkers of oxidative sress, a standardized form of selenium-enriched yeast and reduced prostate cancer risk. Results from long-term clinical trial suggest that selenium-enriched yeast (SY), in a dose-dependent, standardized form from SelenoExcell, but not selenomethionine (SeMet) may be effective at reducing prostate cancer risk. This study confirmed reductions in biomarkers of oxidative stress following supplementation with the standardized form of SY but not SeMet in healthy men. By John P Richie Jr PhD, Karam el-Bayoumy PhD et al, published in Cancer Prevention Research, August 2014.
